A clinical decision-support framework to differentiate radiation necrosis from tumor progression in brain metastases.

Authors

Beatriz Ocaña-Tienda, Zhao Hui Chen Zhou, Ana Ramos, Ana Ortiz de Mendivil, Fatima Nagib-Raya, Beatriz Asenjo, Alberto Bastero, Carlos Tramblin, Estanislao Arana, Víctor M Pérez-García

Published in

Neuro-oncology advances. Volume 8. Issue 1. Pages vdag185. Epub Jul 17, 2026.

Abstract

Differentiating radiation necrosis (RN) from tumor progression (TP) after stereotactic radiotherapy (SRT) in brain metastases (BMs) is a clinically consequential problem, as conventional MRI frequently fails to distinguish between them. Misclassification can lead to inappropriate treatment decisions or delayed therapy. The objective of this study was to develop a clinically interpretable, data-driven model that integrates lesion growth dynamics with routinely available clinical variables to improve discrimination between RN and TP.
We retrospectively analyzed 175 BMs from 6 institutions. Lesion volumes were extracted from three consecutive contrast-enhanced T1-weighted MRI, and growth dynamics were quantified by estimating the growth exponent β. Clinical and treatment-related variables were systematically evaluated, and a multivariable predictive model was trained on a development cohort (n = 131) and validated on an external cohort (n = 44).
The final model combined β, primary tumor histology, and SRT modality. In the development cohort, the model demonstrated strong discriminative performance (AUC = 0.887). External validation confirmed generalizability, achieving an overall accuracy of 0.75, with high specificity (0.85) and positive predictive value (0.92) for RN. Incorrect classifications were largely confined to an intermediate-probability zone, while predictions at low and high probability extremes were highly reliable. The model was translated into a freely accessible, web-based tool to facilitate clinical decision-making.
By integrating lesion growth dynamics with routine clinical variables, this probability-based framework supports clinically meaningful differentiation between RN and TP. Its ability to explicitly represent diagnostic uncertainty, together with external validation, highlights its potential utility as a decision-support tool in the management of BMs.

PMID:
42571295
Bibliographic data and abstract were imported from PubMed on 09 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.